News About: Pharm. Industry
Sluggish sales revenue worries domestic new drug makers
Domestic drug manufacturers, who have rolled out a total of nine new drugs since 1999, worry about lackluster sales performance last year, industry sources said.
The sources attributed such sluggish sales r...
Bukwang sells Saponal granule in OTC market
Bukwang Pharm said recently it has re-launched Saponal granule, which was produced and marketed by Sanofi-Synthelabo Korea after signing a deal to acquire the item.
In an effort to promote a new brand image of Sapo...
GSK wanted clinical testee for inhaler asthmatic drug.
GSK wanted about 500 patients for the multicenter clinical studies of a new inhaler asthmatic drug until June 30, 2004, performing in 20 hospitals across the nation including Seoul, Kyeonggi, Busan and Jeonju areas
...
Korea Meditech to celebrate 5th year anniversary.
Korea Meditech Pharmaceutical company celebrated its 5th anniversary at Hyangnam plant along with a launching event of new product, Spasmax tablet, a spasmolytic drug.
President Kim Sang-il delivered his remarks as...
KFDA to approve GSK's new anesthetic drug, Ultiva
KFDA approved GSK's new anesthetic drug, Ultiva at the end of April.
Ultiva (Remifentanil Hcl) was first approved as a new systemic anesthetic drug in 1996 and its additional indications for a sedative analgesia wa...
Drug-related index likely to gain in second half
With a wide variety of drug-related index showing signs of improvement from the first quarter of this year drug shipment, drug retail sales, and health care services, these factors will likely feed optimism that the ...
CJ to launch new diagnostic for diabetic foot disorders.
CJ Pharmaceutical Div. announced that a new diagnostic product, "Neurocheck" would be launched into the market around the end of June after completionof its health registration to KFDA.
Neurocheck determines rapid...
Lilly Korea raises doubts over survey of erectile dysfunction products
Lilly Korea has recently raised doubts over the reliability of Pfizer Korea’s report citing the survey on the treatment of PDE-5 inhibitors in patients with erectile dysfunction, which was released by Professor Park N...
KPMA and FKI seminar on pharmaceutical industrial development.
Korea Pharmaceutical Manufacturers Association (KPMA) and Federation of Korean Industries (FKI) jointly will hold a seminar under the title of "How to develope Korean pharmaceutical industry in the 21th century" at Or...
Yamouchi Korea grew 25% of sales and 59% of net income.
Yamanouchi Korea reported the FY2003 business performance (11th fiscal year) recording 27,022 million won of sales, about 25.07% up from the previous year, 7,943 million won of operation income, 58.44% up, 7,985 milli...
